Navigation Links
MaV203 Competent Yeast Cells Library Scale from Invitrogen

ProductsMaV203 Competent Yeast Cells Library Scale from Invitrogen
Company Invitrogen
Item MaV203 Competent Yeast Cells Library Scale
Price 
Description MaV203 Competent Yeast Cells are designed for use with the ProQuest Two-Hybrid System (Figure 1). S. cerevisiae strain MaV203 contains deletions in the endogenous GAL4 and GAL80 genes for use with GAL4-based two-hybrid systems. The strain also has leu2 and trp1 mutations for selection of ProQuest bait and prey vectors. MaV203 contains three GAL4 inducible reporter genes, providing four phenotypes, for easier identification of true interactors (Figure 2). The MaV203 competent cells feature:

Transformation (250 l of cells) efficiency yields >1 x 106 colonies
Control DNA pMAB12 to confirm transformation efficiency and the preparation of selection media
Pre-qualified PEG/Lithium Acetate to maximize number of trans-formants
Competent cells formatted with carrier DNA already included
Info InvitrogenInvitrogen
Invitrogen Corporation
1600 Faraday Ave.
Carlsbad, CA 92008

Call Invitrogen to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-521-4270
Customer Service: 800-955-6288
Tech Support: 800-955-6288 ext. 2
Fax Number: 760-603-7229
Web Site: http://www.invitrogen.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. MaV203 Competent Yeast Cells Subcloning Scale from Invitrogen
2. pET GST Fusion System 42 plus Competent Cells from Novagen
3. pET GST Fusion System 41 plus Competent Cells from Novagen
4. BL21 Competent Cell Set* from Novagen
5. SuperScript Plasmid System and MAX Efficiency DH10BCompetent Cells from Invitrogen
6. Zero Blunt TOPO PCR Cloning Kit with One Shot TOP10 Chemically Competent E. coli from Invitrogen
7. Zero Blunt TOPO Kit for Sequencing with One Shot Mach1 T1 Phage-Resistant Chemically Competent E. coli from Invitrogen
8. Zero Blunt TOPO PCR Cloning Kit with One Shot Mach1 T1 Phage-Resistant Chemically Competent E. coli from Invitrogen
9. One Shot INVAlphaF Chemically Competent E. coli from Invitrogen
10. Blunt-ended PCR Cloning Kit / pMOSBlue Competent Cells from GE Healthcare, formerly Amersham Biosciences
11. CopyControl cDNA, Gene and PCR Cloning Kit w/ Chemically Competent E. coli cells from EPICENTRE Biotechnologies
...53; Agarose Gel-Digesting Preparation contains a u... EPICENTRE for simple, quantitative recovery of in...ose gels following electrophoresis in TAE, TBE, MO...directly in the TAE, TBE, MOPS, and phosphate elec...
...heer in-house demand is causing shortages in your ...s antibody. This can cause unwanted distractions, ...for your hard work and endeavour! Bring us your id...nally. We work under ISO 9001 quality assurance in...
...assays for interferons are cytopathic effect inhib...ys. Sample types include; tissue culture supernat...ons. In these assays, one unit is defined as the ...reduce the cytopathic effect of viral infection by...
Mae II from Roche Applied Science
Biology Products:
(Date:11/24/2009)...upus Research Institute (LRI) today named 12 new g...6 million, recognize innovative work across a broa...r their creativity, novelty, and potential to driv...t, and cure the complex disease of systemic lupus....d lupus researchers across the nation and include ...
(Date:11/24/2009)...ger and the American College of Medical Toxicology... the publication of the Journal of Medical Toxico...inning in March 2010. It was previously published... Journal of Medical Toxicology , an international... the science and practice of medical toxicology. ...
(Date:11/24/2009)... release is available in Spanish . , The pr... levels of inflammatory substances in the blood, h... shown by a research project of the University of ...cientist at the School of Pharmacy. , The projec... in relation to the control of body weight and inf...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 1US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 2US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 3US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 4US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 5US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 6US FDA Approves Extavia 28R 29 the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease 4853 7New biofactories produce rare healing substances in the endangered Devils claw plant 54597 1New biofactories produce rare healing substances in the endangered Devils claw plant 54597 2New biofactories produce rare healing substances in the endangered Devils claw plant 54597 3Newly found DNA catalysts cleave DNA with water molecule 9589 1Newly found DNA catalysts cleave DNA with water molecule 9589 2
...in a key brain protein known to underlie a form of...nting the normal growth and branching of neurons, ...alfunction of the protein made by mutant forms of ...ultimately leading to their death. The loss of dop...y of PD, and loss of connections among such neuron...
... simple stream of one-letter characters in the hum...de. In order to decipher this level of architectu...ental and algorithmic methods to detect copy numbe...duplications of DNA segments. These technologies-...were used to create the first comprehensive map of...
...g reasons behind the dramatic increase in testicul...ong 15-to-35-year-old Caucasian men, is the focus ...tute (NCI) grant to Yale Public Health researcher ... for unknown reasons and this study will provide i...netic and other risk factors,?said Zheng, professo...
Other Biology News:Parkinson's mutation stunts neurons 2New technology used to construct the first map of structural variation in the human genome 2
(Date:11/24/2009)...o also Visit Detroit , (V...French Ambassador for International Investment, an... , , , ,What: Ambassador Appia is available to me...atives adopted by France to further develop the fi...ion and development., , ,When: Available for Inter...
(Date:11/24/2009)...rio, Nov. 24 Dow AgroSci...ssets of Hyland Seeds, a division of Thompsons Lim...Seeds will further expand Dow AgroSciences, curren...troduction of SmartStax(TM) in 2010 and Dow ...n corn in 2012. The transactional close is expecte...
(Date:11/24/2009)... employment grew by 29,000 jobs in October, and t...rowth during the U.S. recession. However, clinics ...lth systems are coming closer to having to actuall...ators. , (Vocus) November...ing in October despite the shedding of jobs in mos...
(Date:11/24/2009).... 24 NeurogesX, Inc. (Na... on developing and commercializing novel pain mana...onno, President and Chief Executive Officer, is sc...y Health Care Conference, to be held December 1-2,...w York. ,, Mr. DiTonno and Stephen Ghiglieri, ...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3